Epidemiology and Prevention of Hepatitis B

ABSTRACT

The primary goal of hepatitis B prevention programs is reduction of chronic hepatitis B virus (HBV) infection and HBV-related chronic liver disease. Although donor screening, risk-reduction counseling and services, and effective infection control practices can reduce or eliminate the potential risk for HBV transmission, immunization is by far the single most effective prevention measure. Worldwide, the integration of hepatitis B vaccine into existing childhood vaccination schedules has the greatest likelihood of long-term success. However, by 2000, only 116 of 215 countries had such a policy, representing 31% of the global birth cohort. In addition, efforts must be strengthened to vaccinate older adolescents and adults with high-risk behaviors or occupations in countries where most HBV transmission and the morbidity associated with acute hepatitis B occur among persons in these age groups. Although continued immunization of successive birth cohorts should achieve the eventual elimination of HBV transmission, this will not occur for decades without successful vaccination of adults at increased risk for infection.

KEYWORDS

Hepatitis B - epidemiology - prevention

REFERENCES

• 1 Kane M. Global programme for control of hepatitis B infection.  Vaccine . 1995;  13(Suppl 1) S47-S49
• 2 Beasley R P. Hepatitis B virus. The major etiology of hepatocellular carcinoma.  Cancer . 1988;  61 1942-1956
• 3 Alter H J, Purcell R H, Gerin J L. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.  Infect Immun . 1977;  16 928-933
• 4 Bancroft W H, Snitbhan R, Scott R M. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen.  J Infect Dis . 1977;  135 79-85
• 5 Alter H J, Seeff L B, Kaplan P M. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.  N Engl J Med . 1976;  295 909-913
• 6 Hindman S H, Gravelle C R, Murphy B L. "e" antigen, Dane particles and serum DNA polymerase activity in HBsAg carriers.  Ann Intern Med . 1976;  85 458-460
• 7 Shikata T, Karasawa T, Abe K. Hepatitis B e antigen and infectivity of hepatitis B virus.  J Infect Dis . 1977;  136 571-576
• 8 The Incident Investigation Team and Others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen.  N Engl J Med . 1997;  336 178-184
• 9 Alter H J, Purcell R H, Holland P V. Clinical and serological analysis of transfusion-associated hepatitis.  Lancet . 1975;  2 838-841
• 10 Seeff L B, Wright E C, Zimmerman H J. VA cooperative study of post-transfusion hepatitis and responsible risk factors.  Am J Med Sci . 1975;  270 355-362
• 11 Hutin Y J, Harpaz R, Drobeniuc J. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova.  Int J Epidemiol . 1999;  28 782-786
• 12 Alter M J, Ahtone J, Maynard J E. Multiple-dose vial associated with transmission of hepatitis B virus in a hemodialysis unit.  Ann Intern Med . 1983;  99 330-333
• 13 Polish L B, Shapiro C N, Bauer F. Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device.  N Engl J Med . 1992;  326 721-725
• 14 Hutin Y J, Goldstein S T, Varma J K. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis.  Infect Control Hosp Epidemiol . 1999;  20 731-735
• 15 Drescher J, Wagner D, Haverich A. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy.  J Hosp Infect . 1994;  26 81-92
• 16 Lettau L, McCarthy J G, Smith M H. An outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts.  N Engl J Med . 1987;  317 1256-1261
• 17 Mast E E, Alter M J. Prevention of hepatitis B virus infection among health care workers. In: Ellis RS, ed. Hepatitis B Vaccines in Clinical Practice New York: Marcel Dekker 1992: 295-307
• 18 Limentani A E, Elliott L M. An outbreak of hepatitis B from tattooing.  Lancet . 1979;  2 86-88
• 19 Kent G B, Brondum J, Keenlyside R A, LaFazia L M, Scott H D. A large outbreak of acupuncture-associated hepatitis B.  Am J Epidemiol . 1988;  127 591-598
• 20 Bond W W, Favero M S, Petersen N J. Survival of hepatitis B virus after drying and storage for one week.  Lancet . 1981;  1 550-551
• 21 Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients.  MMWR Recomm Rep . 2001;  50(RR-5) 1-43
• 22 Quale J M, Landman D, Wallace B. Déjà vu: nosocomial hepatitis B virus transmission and fingerstick monitoring.  Am J Med . 1998;  105 296-301
• 23 Douvin C, Simon D, Zinelabidine H. An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device.  N Engl J Med . 1990;  322 57-58
• 24 Vickers J, Painter M J, Heptonstall J, Yusaf J HM, Craske J. Hepatitis B outbreak in a drug trials unit: investigation and recommendations.  Commun Dis Rep . 1994;  4 R1-R5
• 25 Oren I, Hershow R C, Ben-Porath E. A common-source outbreak of fulminant hepatitis B in a hospital.  Ann Intern Med . 1989;  110 691-698
• 26 Dienstag J L, Ryan D M. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization.  Am J Epidemiol . 1982;  115 26-39
• 27 Hadler S C, Doto I L, Maynard J E. Occupational risk of hepatitis B infection in hospital workers.  Infect Control . 1985;  6 24-31
• 28 Mahoney F J, Stewart K, Hu H. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.  Arch Intern Med . 1997;  157 2601-2605
• 29 Carl M, Blakey D L, Francis D P, Maynard J E. Interruption of hepatitis B transmission by modification of a gynaecologist's surgical technique.  Lancet . 1982;  1 731-733
• 30 Lettau L A, Smith J D, Williams D. Transmission of hepatitis B with resultant restriction of surgical practice.  JAMA . 1986;  255 934-937
• 31 Prendergast T J, Teitelbaum S, Peck B. Transmission of hepatitis B by a surgeon [letter].  West J Med . 1991;  154 353
• 32 Levin M L, Maddrey W C, Wands J R, Mendeloff A I. Hepatitis B transmission by dentists.  JAMA . 1974;  228 1139-1140
• 33 Goodwin D, Fannin S T, McCracken B B. An oral-surgeon related hepatitis-B outbreak.  Calif Morbid . 1976;  14 1-2
• 34 Rimland D, Parkin W E, Miller G B, Schrack W D. Hepatitis B outbreak traced to an oral surgeon.  N Engl J Med . 1977;  296 953-958
• 35 Hadler S C, Sorley D L, Acree K H. An outbreak of hepatitis B in a dental practice.  Ann Intern Med . 1981;  95 133-138
• 36 Reingold A L, Kane M A, Murphy B L. Transmission of hepatitis B by an oral surgeon.  J Infect Dis . 1982;  145 262-268
• 37 Ahtone J, Goodman R A. Hepatitis B and dental personnel: transmission to patients and prevention issues.  J Am Dent Assoc . 1983;  106 219-222
• 38 Goodman R A, Ahtone J L, Finton R J. Hepatitis B transmission from dental personnel to patients: unfinished business [editorial].  Ann Intern Med . 1983;  96 119
• 39 Shaw F E, Barrett C L, Hamm R. Lethal outbreak of hepatitis B in a dental practice.  JAMA . 1986;  255 3260-3264
• 40 CDC. Outbreak of hepatitis B associated with an oral surgeon-New Hampshire.  MMWR Morb Mortal Wkly Rep . 1987;  38 132-133
• 41 Public Health Laboratory Service. Acute hepatitis B associated with gynaecological surgery: a report of a collaborative study by the Communicable Disease Surveillance Centre and the Epidemiological Research Laboratory of the Public Health Laboratory Service together with a district control-of-infection service.  Lancet . 1980;  1 595-596
• 42 Haerem J W, Siebke J C, Ulstrup J, Geiran O, Helle I. HBsAg transmission from a cardiac surgeon incubating hepatitis B resulting in chronic antigenemia in four patients.  Acta Med Scand . 1981;  210 389-392
• 43 District Control of Infection Officer. Acute hepatitis B following gynaecological surgery.  J Hosp Infect . 1987;  9 34-38
• 44 Coutinho R A, Albrecht-van Lent P, Stoutjesdijk L. Hepatitis B from doctors [letter].  Lancet . 1982;  1 345-346
• 45 Polakoff S. Acute hepatitis B in Britain related to previous operations and dental treatment.  Br Med J . 1986;  293 33-36
• 46 Welch J, Webster M, Tilzey A J, Noah N D. Hepatitis B infections after gynaecological surgery.  Lancet . 1989;  1 205-207
• 47 Polakoff S. Acute viral hepatitis B, reported to the Public Health Laboratory Service.  J Infect . 1990;  20 163-168
• 48 Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff.  Commun Dis Rep . 1991;  1 R81-R85
• 49 Prentice M B, Flower A JE, Morgan G M. Infection with hepatitis B virus after open heart surgery.  Br Med J . 1992;  304 761-764
• 50 Johnston B L, MacDonald S, Lee S. Nosocomial hepatitis B associated with orthopedic surgery-Nova Scotia.  Can Commun Dis Rep . 1992;  18 89-90
• 51 Snydman D R, Hindman S H, Wineland M D, Bryan J A, Maynard J E. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients.  Ann Intern Med . 1976;  85 573-577
• 52 Grob P J, Bischof B, Naeff F. Cluster of hepatitis B transmitted by a physician.  Lancet . 1981;  2 1218-1220
• 53 Johnson I. Hepatitis B-EEG clinics outbreak investigation: final report, January 1997. Ontario Ministry of Health, Toronto, Canada
• 54 Harpaz R, Von Seidlin L, Averhoff F M. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control.  N Engl J Med . 1996;  334 549-554
• 55 Spijkerman I JB, van Doorn L-J, Janssen M HW. Transmission of hepatitis B virus from a surgeon to his patients during high-risk low-risk surgical procedures during 4 years.  Infect Control Hosp Epidemiol . 2002;  23 306-312
• 56 Stevens C E, Neurath R A, Beasley R P. HBeAg and anti-HBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B virus in Taiwan.  J Med Virol . 1979;  3 237-241
• 57 Alter M J, Margolis H S. The emergence of hepatitis B as a sexually transmitted disease.  Med Clin North Am . 1990;  74 1529-1541
• 58 Centers for Disease Control. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigen-positive saliva.  Morbidity and Mortality Weekly Report . 1978;  27 247-248
• 59 Glaser J B, Nadler J P. Hepatitis B virus in a cardiopulmonary resuscitation training course.  Arch Intern Med . 1985;  145 1653-1655
• 60 Xu Z Y, Liu C B, Francis D P. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized double-blind placebo-controlled and comparative trial.  Pediatrics . 1985;  76 713-718
• 61 Beasley R P, Hwang L-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers.  J Infect Dis . 1983;  147 185-190
• 62 Franks A L, Berg C J, Kane M A. Hepatitis B infection among children born in the United States to Southeast Asian refugees.  N Engl J Med . 1989;  321 1301-1305
• 63 Hurie M B, Mast E E, Davis J P. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees.  Pediatrics . 1992;  89 269-273
• 64 Toukan A U, Sharaiha Z K, Abu-el-rub O A. The epidemiology of hepatitis B virus among family members in the Middle East.  Am J Epidemiol . 1990;  132 220-232
• 65 Pon E W, Ren H X, Margolis H S. Hepatitis B virus infection in Honolulu students.  Pediatrics . 1993;  92 574-578
• 66 Bernier R H, Sampliner R, Gerety R. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection.  Am J Epidemiol . 1982;  116 199-211
• 67 Szmuness W, Harley E J, Prince A M. Intrafamilial spread of asymptomatic hepatitis B.  Am J Med Sci . 1975;  270 293-304
• 68 Petersen N J, Barrett D H, Bond W H. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages.  Appl Environ Microbiol . 1976;  32 572-574
• 69 Margolis H S, Alter M J, Hadler S C. Hepatitis B: evolving epidemiology and implications for control.  Semin Liver Dis . 1991;  11 84-92
• 70 Margolis H S, Alter M J, Hadler S C. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans, 4th ed New York: Plenum Medical Book 1997: 363-418
• 71 Bogomolski-Yahalom V, Granot E, Linder N. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk.  J Med Virol . 1991;  34 217-222
• 72 Germinario C, Lopalco P L, Chicanna M, Da Villa G. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.  Vaccine . 2000;  18 S83-S85
• 73 Spada E, Mele A, Ciccozzi M. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy.  Dig Liver Dis . 2001;  33 778-784
• 74 Van Steenbergen E J, Niesters H GM, Op de Coul L M E. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997.  J Med Virol . 2002;  66 159-165
• 75 Goldstein S T, Alter M J, Williams I T. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998; implications for vaccination programs.  J Infect Dis . 2002;  185 713-719
• 76 Connolly J H, McClelland W M, O'Neill H J, Crowley D. Hepatitis B virus infection in Northern Ireland 1970-1987.  Ulster Med J . 1989;  58 72-82
• 77 Brabin B, Beeching N J, Bunn J EG. Hepatitis B prevalence among Somali households in Liverpool.  Arch Dis Child . 2002;  86 67-68
• 78 Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP).  Morbidity and Mortality Weekly Report . 1991;  40(RR-13) 1-25
• 79 Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission in the United States.  Morbidity and Mortality Weekly Report . 1995;  44 574-575
• 80 Healy C M, Cafferkey M T, Butler K M. Antenatal hepatitis B screening-is there a need for a national policy?.  Irish Med J . 2001;  94 111-112
• 81 Van Steenbergen E J, Leentvaar-Kuijpers A, Baayen D. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998.  Vaccine . 2001;  20 7-11
• 82 Salleras L, Bruguera M, Vidal J. Prevalence of markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.  Eur J Epidemiol . 1992;  8 640-644
• 83 Da Villa G. Rationale for the infant and adolescent vaccination programmes in Italy.  Vaccine . 2000;  18 S31-S34
• 84 Magdzik W. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states.  Vaccine . 2000;  18 S13-S16
• 85 Popa I M, Pistol A, Mast E E. Use of surveillance for acute hepatitis among children to assess the impact of routine infant hepatitis B vaccination programs in Romania. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease Atlanta: International Medical Press 2002: 261-262
• 86 Ni Y-H, Chang M-H, Huang L-M. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.  Ann Intern Med . 2001;  135 796-800
• 87 Chang M H, Chen C J, Lai M S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.  N Engl J Med . 1997;  336 1855-1859
• 88 Da Villa G , Sepe A , Piccinino F , Scolastico c . Pilot project of universal hepatitis B vaccination of newborns in a hyperendemic area: results after 17 years. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. Atlanta: International Medical Press 2002: 258-260
• 89 Armstrong G L, Mast E E, Wojczynski M, Margolis H S. Childhood hepatitis B virus infections in the United States before hepatitis B immunization.  Pediatrics . 2001;  108 1123-1128
• 90 Centers for Disease Control. Current trends in hepatitis B virus vaccine safety: report of an inter-agency group.  MMWR . 1982;  31 465-467
• 91 Centers for Disease Control. Hepatitis B vaccine: evidence confirming lack of AIDS transmission.  MMWR . 1984;  33 685-687
• 92 Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines-a review.  Vaccine . 1998;  16 329-324
• 93 Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis.  N Engl J Med . 2001;  344 319-326
• 94 Ascherio A, Zhang S M, Hernán M A. Hepatitis B vaccination and the risk of multiple sclerosis.  N Engl J Med . 2001;  344 327-332
• 95 Institute of Medicine Immunization Safety Review Committee. In: Stratton K, Almario D, McCormick MC, eds. Hepatitis B Vaccine and Demyelinating Disorders, Washington, DC: National Academy Press 2002: 1-106
• 96 Francois G, Kew M, Van Damme P, Mphahlele M J, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?.  Vaccine . 2001;  19 3799-3815
• 97 Hsu H-Y, Chang M-H, Liaw S-H, Ni Y-H, Chen H-L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan.  Hepatology . 1999;  30 1312-1317
• 98 Nainan O V, Khristova M L, Byun K-S. Frequency and significance of hepatitis B virus antibody resistant mutants (Abst).  Antiviral Ther . 2000;  5(Suppl) 29-30
• 99 Ogata N, Cote P J, Zanetti A R. Licensed recombinant hepatitis B vaccine protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.  Hepatology . 1999;  30 779-786